share_log

Scotiabank Initiates Coverage On Tempest Therapeutics With Sector Outperform Rating, Announces Price Target of $13

Scotiabank Initiates Coverage On Tempest Therapeutics With Sector Outperform Rating, Announces Price Target of $13

丰业银行开始对Tempest Therapeutics进行报道,评级为行业跑赢大盘,宣布目标股价为13美元
Moomoo 24/7 ·  03/13 17:24

Scotiabank analyst George Farmer initiates coverage on Tempest Therapeutics (NASDAQ:TPST) with a Sector Outperform rating and announces Price Target of $13.

丰业银行分析师乔治·法默以行业跑赢大盘的评级启动了对Tempest Therapeutics(纳斯达克股票代码:TPST)的报道,并宣布目标股价为13美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发